{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T11:35:09Z","timestamp":1789731309114,"version":"4.0.1"},"reference-count":45,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2023,4,18]],"date-time":"2023-04-18T00:00:00Z","timestamp":1681776000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Doxycycline is a drug that has been proposed to modify osteoarthritis (OA) progression, in addition to its role as an antibiotic. However, available evidence thus far comprises sporadic reports, with no consensus on its benefits. Hence, this review attempts to analyze the evidence available thus far on the role of doxycycline as a disease-modifying osteoarthritis drug (DMOAD) in knee osteoarthritis. The earliest evidence of doxycycline in OA appeared in 1991 when doxycycline was found to inhibit the type XI collagenolytic activity of extracts from the human osteoarthritic cartilage, and gelatinase and tetracycline were found to inhibit this metalloproteinase activity in articular cartilage in vivo, which could modify cartilage breakdown in osteoarthritis. Apart from the inhibition of cartilage damage by metalloproteinases (MMPs) and other cartilage-related mechanisms, doxycycline also affects the bone and interferes with many enzyme systems. The most significant finding after reviewing various studies was that doxycycline has a definitive role in structural changes in osteoarthritis progression and radiological joint space width, but its role in the improvement of clinical outcomes as a DMOAD has not been established. However, there is much of a gap and lack of evidence in this regard. Doxycycline, as an MMP inhibitor, has theoretical advantages for clinical outcomes, but the present studies reveal only beneficial structural changes in osteoarthritis and very minimal or nonexistent advantages in clinical outcomes. Current evidence does not favor the regular use of doxycycline for the treatment of osteoarthritis as an individual treatment option or in combination with others. However, multicenter large cohort studies are warranted to determine the long-term benefits of doxycycline.<\/jats:p>","DOI":"10.3390\/jcm12082927","type":"journal-article","created":{"date-parts":[[2023,4,18]],"date-time":"2023-04-18T02:30:03Z","timestamp":1681785003000},"page":"2927","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Role of Doxycycline as an Osteoarthritis Disease-Modifying Drug"],"prefix":"10.3390","volume":"12","author":[{"given":"Saseendar","family":"Shanmugasundaram","sequence":"first","affiliation":[{"name":"Sri Lakshmi Narayana Institute of Medical Sciences, Chennai 605502, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ketansinh","family":"Solanki","sequence":"additional","affiliation":[{"name":"Bankers Group of Hospital, Vadodara 390007, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samudeeswari","family":"Saseendar","sequence":"additional","affiliation":[{"name":"Sri Lakshmi Narayana Institute of Medical Sciences, Chennai 605502, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay K.","family":"Chavada","sequence":"additional","affiliation":[{"name":"Department of Community Medicine, Indira Gandhi Medical College and Research Institute, Puducherry 605009, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1216-792X","authenticated-orcid":false,"given":"Riccardo","family":"D\u2019Ambrosi","sequence":"additional","affiliation":[{"name":"IRCCS Ospedale Galeazzi\u2014Sant\u2019Ambrogio, 20161 Milan, Italy"},{"name":"Dipartimento di Scienze Biomediche per la Salute, Universit\u00e0 degli Studi di Milano, 20133 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,4,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.mcna.2019.10.007","article-title":"Osteoarthritis: Pathology, Diagnosis, and Treatment Options","volume":"104","author":"Abramoff","year":"2020","journal-title":"Med. Clin. N. Am."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/s41584-022-00749-9","article-title":"Synovial inflammation in osteoarthritis progression","volume":"18","author":"Coras","year":"2022","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.joca.2021.11.009","article-title":"Osteoarthritis year in review 2021: Biology","volume":"30","author":"Jiang","year":"2022","journal-title":"Osteoarthr. Cartil."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"D\u2019Ambrosi, R., Valli, F., De Luca, P., Ursino, N., and Usuelli, F.G. (2019). MaioRegen Osteochondral Substitute for the Treatment of Knee Defects: A Systematic Review of the Literature. J. Clin. Med., 8.","DOI":"10.3390\/jcm8060783"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Serrano, D.V., Saseendar, S., Shanmugasundaram, S., Bidwai, R., G\u00f3mez, D., and D\u2019Ambrosi, R. (2022). Spontaneous Osteonecrosis of the Knee: State of the Art. J. Clin. Med., 11.","DOI":"10.3390\/jcm11236943"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"105206","DOI":"10.1016\/j.jbspin.2021.105206","article-title":"Osteoarthritis: From upcoming treatments to treatments yet to come","volume":"88","author":"Delplace","year":"2021","journal-title":"Jt. Bone Spine"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s00167-022-07218-6","article-title":"Similar survivorship at the 5-year follow-up comparing robotic-assisted and conventional lateral unicompartmental knee arthroplasty","volume":"31","author":"Maritan","year":"2022","journal-title":"Knee Surg. Sport Traumatol. Arthrosc."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jor.2022.09.006","article-title":"High tibial osteotomy with an external fixator or unicompartmental knee arthroplasty for varus knee in young patients?","volume":"34","author":"Yadav","year":"2022","journal-title":"J. Orthop."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Gobbi, A., Dallo, I., and D\u2019Ambrosi, R. (2022). Autologous microfragmented adipose tissue and leukocyte-poor platelet-rich plasma combined with hyaluronic acid show comparable clinical outcomes for symptomatic early knee osteoarthritis over a two-year follow-up period: A prospective randomized clinical trial. Eur. J. Orthop. Surg. Traumatol., Epub ahead of print.","DOI":"10.1007\/s00590-022-03356-2"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1136\/ard.2010.147967","article-title":"The effects of doxycycline on reducing symptoms in knee osteoarthritis: Results from a triple-blinded randomized controlled trial","volume":"70","author":"Snijders","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.joca.2014.01.005","article-title":"Pharmacologic regimens for knee osteoarthritis prevention: Can they be cost-effective?","volume":"22","author":"Losina","year":"2014","journal-title":"Osteoarthr. Cartil."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/01.bor.0000218945.96988.0a","article-title":"An update on osteoarthritis therapeutics","volume":"18","author":"Hogenmiller","year":"2006","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1056\/NEJMc060829","article-title":"Glucosamine and chondroitin sulfate for knee osteoarthritis","volume":"354","author":"Pelletier","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1177\/0091270010372625","article-title":"Lessons learned from the development of oral calcitonin: The first tablet formulation of a protein in phase III clinical trials","volume":"51","author":"Karsdal","year":"2011","journal-title":"J. Clin. Pharmacol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1136\/ard.2007.075572","article-title":"Effects of strontium ranelate on spinal osteoarthritis progression","volume":"67","author":"Bruyere","year":"2008","journal-title":"Ann. Rheum. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3494","DOI":"10.1002\/art.22160","article-title":"Risedronate decreases biochemical markers of cartilage degradation but does not decrease symptoms or slow radiographic progression in patients with medial compartment osteoarthritis of the knee: Results of the two-year multinational knee osteoarthritis structural arthritis study","volume":"54","author":"Bingham","year":"2006","journal-title":"Arthritis Rheum."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1136\/annrheumdis-2011-200970","article-title":"Zoledronic acid reduces knee pain and bone marrow lesions over 1 year: A randomized controlled trial","volume":"71","author":"Laslett","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/rheumatology\/kei171","article-title":"Chondroprotective drugs in degenerative joint diseases","volume":"45","author":"Verbruggen","year":"2006","journal-title":"Rheumatology"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.bone.2012.03.025","article-title":"Inhibition of cathepsin K reduces cartilage degeneration in the anterior cruciate ligament transection rabbit and murine models of osteoarthritis","volume":"50","author":"Hayami","year":"2012","journal-title":"Bone"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/art.33398","article-title":"Osteoarthritic change is delayed in a Ctsk-knockout mouse model of osteoarthritis","volume":"64","author":"Kozawa","year":"2012","journal-title":"Arthritis Rheum."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/00006982-200102000-00005","article-title":"Matrix metalloproteinases in human diabetic and nondiabetic vitreous","volume":"21","author":"Jin","year":"2001","journal-title":"Retina"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.2174\/1874467214666210210122628","article-title":"Minocycline and Doxycycline: More Than Antibiotics","volume":"14","author":"Singh","year":"2021","journal-title":"Curr. Mol. Pharmacol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1080\/03602532.2019.1687511","article-title":"Systemic drugs with impact on osteoarthritis","volume":"51","author":"Apostu","year":"2019","journal-title":"Drug Metab. Rev."},{"key":"ref_24","first-page":"1450","article-title":"Doxycycline inhibits type XI collagenolytic activity of extracts from human osteoarthritic cartilage and of gelatinase","volume":"18","author":"Yu","year":"1991","journal-title":"J. Rheumatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"115214","DOI":"10.1016\/j.bone.2019.115214","article-title":"Effect of inducible bone morphogenetic protein 2 expression on the osteogenic differentiation of dental pulp stem cells in vitro","volume":"132","year":"2020","journal-title":"Bone"},{"key":"ref_26","first-page":"532","article-title":"Oral administration of doxycycline reduces collagenase and gelatinase activities in extracts of human osteoarthritic cartilage","volume":"25","author":"Smith","year":"1998","journal-title":"J. Rheumatol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.joca.2020.01.007","article-title":"Macrophages regulate the progression of osteoarthritis","volume":"28","author":"Zhang","year":"2020","journal-title":"Osteoarthr. Cartil."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"116786","DOI":"10.1016\/j.lfs.2019.116786","article-title":"The role of matrix metalloproteinases in osteoarthritis pathogenesis: An updated review","volume":"234","author":"Mehana","year":"2019","journal-title":"Life Sci."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.joca.2018.03.007","article-title":"Bone morphogenetic proteins for articular cartilage regeneration","volume":"26","author":"Deng","year":"2018","journal-title":"Osteoarthr. Cartil."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Hu, Q., and Ecker, M. (2021). Overview of MMP-13 as a Promising Target for the Treatment of Osteoarthritis. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22041742"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.18632\/aging.204018","article-title":"Circular RNA circ_0000423 regulates cartilage ECM synthesis via circ_0000423\/miRNA-27b-3p\/MMP-13 axis in osteoarthritis","volume":"14","author":"Li","year":"2022","journal-title":"Aging"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1002\/1529-0131(199906)42:6<1140::AID-ANR10>3.0.CO;2-7","article-title":"Specificity of inhibition of matrix metalloproteinase activity by doxycycline: Relationship to structure of the enzyme","volume":"42","author":"Smith","year":"1999","journal-title":"Arthritis Rheum."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1002\/art.21122","article-title":"Effects of doxycycline on progression of osteoarthritis: Results of a randomized, placebo-controlled, double-blind trial","volume":"52","author":"Brandt","year":"2005","journal-title":"Arthritis Rheum."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/1529-0131(199904)42:4<719::AID-ANR15>3.0.CO;2-T","article-title":"Differential patterns of response to doxycycline and transforming growth factor beta1 in the down-regulation of collagenases in osteoarthritic and normal human chondrocytes","volume":"42","author":"Shlopov","year":"1999","journal-title":"Arthritis Rheum."},{"key":"ref_35","first-page":"835","article-title":"Regulation of cartilage collagenase by doxycycline","volume":"28","author":"Shlopov","year":"2001","journal-title":"J. Rheumatol."},{"key":"ref_36","first-page":"CD007323","article-title":"Doxycycline for osteoarthritis of the knee or hip","volume":"4","author":"Rutjes","year":"2009","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_37","first-page":"CD007323","article-title":"Doxycycline for osteoarthritis of the knee or hip","volume":"11","author":"Reichenbach","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.joca.2010.03.018","article-title":"Varus malalignment negates the structure-modifying benefits of doxycycline in obese women with knee osteoarthritis","volume":"18","author":"Mazzuca","year":"2010","journal-title":"Osteoarthr. Cartil."},{"key":"ref_39","first-page":"1147","article-title":"Associations between joint space narrowing and molecular markers of collagen and proteoglycan turnover in patients with knee osteoarthritis","volume":"33","author":"Mazzuca","year":"2006","journal-title":"J. Rheumatol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1177\/08959374980120012001","article-title":"The potential role of doxycycline in the treatment of osteoarthritis of the temporomandibular joint","volume":"12","author":"Israel","year":"1998","journal-title":"Adv. Dent. Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/RHU.0000000000000095","article-title":"Pilot open observations on doxycycline treatment for erosive osteoarthritis of the hand","volume":"21","author":"Ma","year":"2015","journal-title":"J. Clin. Rheumatol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1517\/14740338.2016.1133584","article-title":"Revisiting doxycycline in pregnancy and early childhood--time to rebuild its reputation?","volume":"15","author":"Cross","year":"2016","journal-title":"Expert Opin. Drug Saf."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1517\/14740338.7.5.571","article-title":"The use and safety of doxycycline hyclate and other second-generation tetracyclines","volume":"7","author":"Sloan","year":"2008","journal-title":"Expert Opin. Drug Saf."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1001\/archderm.142.8.1081","article-title":"Doxycycline-induced staining of adult teeth: The first reported case","volume":"142","author":"Nelson","year":"2006","journal-title":"Arch. Dermatol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/j.1552-4604.1988.tb03160.x","article-title":"A double-blind, multiple-dose, placebo-controlled, cross-over study to compare the incidence of gastrointestinal complaints in healthy subjects given Doryx R and Vibramycin R","volume":"28","author":"Berger","year":"1988","journal-title":"J. Clin. Pharmacol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/8\/2927\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:17:55Z","timestamp":1760123875000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/8\/2927"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,18]]},"references-count":45,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,4]]}},"alternative-id":["jcm12082927"],"URL":"https:\/\/doi.org\/10.3390\/jcm12082927","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,18]]}}}